Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. McKesson Corporation
  6. Summary
    MCK   US58155Q1031

MCKESSON CORPORATION

(MCK)
  Report
Delayed Nyse  -  04:04 2022-07-01 pm EDT
329.53 USD   +1.02%
06/29McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
BU
06/27The Oncology Institute, McKesson Expand Drug Distribution Collaboration
MT
06/27The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
326.24(c) 321.55(c) 328.06(c) 326.21(c) 329.53(c) Last
921 756 852 767 1 080 472 1 215 856 826 566 Volume
+1.46% -1.44% +2.02% -0.56% +1.02% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 268 B - -
Net income 2023 2 858 M - -
Net Debt 2023 978 M - -
P/E ratio 2023 16,9x
Yield 2023 0,59%
Sales 2024 275 B - -
Net income 2024 2 854 M - -
Net Debt 2024 264 M - -
P/E ratio 2024 16,2x
Yield 2024 0,62%
Capitalization 47 314 M 47 314 M -
EV / Sales 2023 0,18x
EV / Sales 2024 0,17x
Nbr of Employees 66 500
Free-Float 52,4%
More Financials
Company
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (94.6%); - distribution of medical and surgical products (4.2%); - other (1.2%): primarily technology services and software sales. The United States accounts for 84.9% of net sales. 
Read more
Sector
Drug Retailers
Calendar
07/22 | 09:30amShareholder meeting
More about the company
Ratings of McKesson Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about MCKESSON CORPORATION
06/29McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
BU
06/27The Oncology Institute, McKesson Expand Drug Distribution Collaboration
MT
06/27The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distrib..
CI
06/24MCKESSON CORPORATION(NYSE : MCK) added to Russell Top 200 Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) added to Russell 1000 Growth-Defensive Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) dropped from Russell Midcap Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) added to Russell 1000 Value-Defensive Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) added to Russell Top 200 Value Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) added to Russell Top 200 Growth Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) dropped from Russell Midcap Growth Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) dropped from Russell Midcap Value Index
CI
06/24MCKESSON CORPORATION(NYSE : MCK) added to Russell 1000 Defensive Index
CI
06/23HCA Healthcare, McKesson to Establish Oncology Research Joint Venture
MT
06/23McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture t..
AQ
06/23McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture t..
BU
More news
News in other languages on MCKESSON CORPORATION
06/27L'Institut d'Oncologie annonce une entente stratégique élargie avec McKesson pour la di..
06/24EN DIRECTO DESDE LOS MERCADOS : Indra, Alphabet, Leonardo, Fedex, Zalando, Mercedes, Atlan..
06/24BOLSA DE MADRID : Dos por docena
06/24Deux à la douzaine
06/24EN DIRECT DES MARCHES : Stellantis, Sanofi, Capgemini, GTT, Fedex, Zalando, Mercedes, Atla..
More news
Analyst Recommendations on MCKESSON CORPORATION
More recommendations
Stock Trading Strategies
MCKESSON CORPORATION - 03/28
The underlying trend is in force again
BUY
More Stock Trading Analysis
Analysis
Walgreens, Teva accused of fueling opioid addiction in quest for new markets
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 329,53 $
Average target price 362,31 $
Spread / Average Target 9,95%
EPS Revisions
Managers and Directors
Brian Scott Tyler Chief Executive Officer & Director
Britt J. Vitalone Chief Financial Officer & Executive Vice President
Donald R. Knauss Independent Chairman
Nancy Flores Chief Technology & Information Officer, EVP
Maria Teresa Lensing Chief Technology Officer-Engineering & SVP
Sector and Competitors
1st jan.Capi. (M$)
MCKESSON CORPORATION32.57%47 314
WALGREENS BOOTS ALLIANCE, INC.-26.07%33 326
CARDINAL HEALTH, INC.3.13%14 466
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD-7.75%9 142
SINOPHARM GROUP CO. LTD.12.15%7 685
YIFENG PHARMACY CHAIN CO., LTD.-1.80%5 804